[Lessons from the Hokkaido COPD cohort study].

Area of Science:

• Respiratory Medicine
• Pulmonology
• Clinical Research

Context:

• The Hokkaido COPD cohort study was a 10-year prospective observational study.
• It investigated variations in disease progression and identified predictive biomarkers in Chronic Obstructive Pulmonary Disease (COPD).

Purpose:

• To analyze the variability in airflow limitation decline among COPD patients.
• To identify factors, including emphysema severity and biomarkers, associated with the rate of forced expiratory volume in 1 second (FEV1) decline.
• To assess the impact of COPD progression on quality of life (QOL).

Summary:

• Emphysema severity, independent of baseline pulmonary function, significantly influenced the annual decline in FEV1 over five years.
• A lower leptin/adiponectin ratio was identified as a novel biomarker predicting rapid FEV1 decline in COPD, validated in an independent cohort.
• While total SGRQ scores correlated with FEV1 decline, the activity component of QOL worsened universally, whereas symptoms often improved with treatment.

Impact:

• Provides novel insights into COPD progression variability and identifies a potential biomarker for predicting decline.
• Highlights the importance of monitoring emphysema severity and metabolic markers for personalized COPD management.
• Demonstrates differential effects of COPD on various aspects of quality of life, emphasizing the need for targeted interventions.